Changes coming to U.S. import regulations, effective August 29th, 2025. All shipments may be affected. Read more for continued updates.

What Are the Possible Side Effects of Repatha?

Mahshid Moghei, PhD Medically reviewed by Mahshid M. on

Repatha Side Effects and Safety Overview

Repatha can cause common, mild effects such as flu-like symptoms, upper respiratory infections, and musculoskeletal aches. Injection-site reactions—redness, swelling, itching, warmth, bruising, or pain—are frequent but usually self-limited; rotating sites and cool compresses help. Rare but serious events include allergic reactions with facial or throat swelling, liver injury, elevated blood sugar or new-onset diabetes, and severe muscle damage. Persistent, worsening, or alarming symptoms warrant prompt medical attention, and more detailed guidance follows below.

Key Takeaways

  • Common mild effects include flu-like symptoms, upper respiratory infections, and nasopharyngitis.

  • Injection-site reactions (pain, redness, swelling, itching, or bruising) are frequent and usually self-limited.

  • Rare but serious allergic reactions can cause facial/throat swelling, hives, and difficulty breathing.

  • Uncommon metabolic effects include a small increase in new-onset diabetes or elevated blood sugar.

  • Seek urgent care for severe muscle pain, dark urine, jaundice, or signs of severe hypersensitivity.

Common and Mild Side Effects

How might Repatha affect everyday comfort? Repatha can produce mild side effects that resemble common illnesses and local reactions. Patients often report flu-like symptoms such as runny nose, sore throat, and general malaise, alongside documented upper respiratory infections and nasopharyngitis. Sinus infections may also occur, contributing to congestion or sinus pressure. Musculoskeletal complaints like back pain and occasional muscle or joint discomfort are noted. Injection site reactions — redness, warmth, itching, bruising, swelling, or pain at the thigh, abdomen, or upper arm — are common but typically resolve over time. Some trials observed elevated blood sugar or new-onset diabetes in a minority of patients, so monitoring and consultation with a clinician are advised if symptoms persist or worsen.

Injection-Site Reactions and How to Manage Them

Alongside systemic symptoms like nasal congestion and muscle aches, many patients experience localized reactions where Repatha is injected. Injection-site reactions commonly include redness, pain, swelling, warmth, itching or bruising at the thigh, abdomen, or upper arm. These effects are usually mild and self-limited but can be bothersome.

To manage symptoms, allow the prefilled syringe to reach room temperature for at least 30 minutes before injection and avoid using areas that are bruised or damaged. Patients should rotate injection sites—alternating among the thigh, abdomen (staying at least two inches from the navel), and outer upper arm—to reduce cumulative irritation. Apply a cool compress or gentle pressure after injection if needed. Contact a clinician if redness, swelling, or pain persist, worsen, or are accompanied by fever.

Less Common but Serious Adverse Effects

Why should patients and clinicians remain alert for less common but serious adverse effects of Repatha? Serious hypersensitivity reactions, including angioedema with facial or throat swelling, hives, and difficulty breathing or swallowing, have been reported and require urgent care. Rare but important hepatic events include liver injury; monitoring and evaluation are advised if symptoms such as jaundice, dark urine, or abdominal pain occur. Trials observed a higher incidence of new-onset diabetes or elevated blood sugar versus placebo, so metabolic screening and follow-up are prudent. Although uncommon, severe muscle damage including rhabdomyolysis has been reported, particularly with concomitant lipid-lowering agents. Prompt recognition and medication review are essential to mitigate these low-frequency but potentially severe risks.

Metabolic Effects: Blood Sugar and Diabetes Risk

When monitoring patients on Repatha, clinicians should be aware of observed effects on glycemic control and the modestly increased incidence of new-onset diabetes seen in some large cardiovascular trials (approximately 8.8% vs 8.2% with placebo). Repatha has been associated with metabolic effects including episodes of hyperglycemia and a small increase in diabetes risk in outcome trials, though not all studies showed this. Regular blood sugar monitoring is advised for patients with diabetes or prediabetes. Patients should report symptoms such as thirst, polyuria, fatigue, or dry mouth. Clinical follow-up should include assessment of metabolic effects alongside other adverse events, with adjustments to diabetes therapy as needed.

Issue

Frequency

Recommended action

Hyperglycemia

Uncommon

Monitoring blood sugar

New diabetes

Modest ↑

Clinical follow-up

When to Seek Medical Attention

How should patients respond if side effects arise after a Repatha dose? Patients should seek immediate medical help for any signs of an allergic reaction, including trouble breathing or swallowing, hives, or swelling of the face, lips, tongue, or throat. Contact a healthcare provider promptly if injection-site reactions such as severe redness, persistent pain, swelling, or bruising occur. Report flu-like symptoms that worsen or do not improve. Any unusual or severe effects—severe muscle pain, dark urine, or symptoms suggesting organ dysfunction—require urgent evaluation. Because trials noted possible effects on blood sugar, report persistent thirst, frequent urination, unexplained weight loss, or other signs of high blood sugar. Inform clinicians of latex allergy risk related to some delivery-device components.

Frequently Asked Questions

What Are the Bad Side Effects of Repatha?

Serious reactions include severe allergic responses (breathing or swallowing difficulty, facial or throat swelling, hives) and rare angioedema; other problematic effects can be persistent high blood sugar, severe muscle pain, liver issues, or worsening injection-site reactions.

Why Are They Discontinuing Repatha?

They are discontinuing Repatha due to individual adverse effects, safety concerns like allergic reactions or elevated blood sugar, persistent injection-site problems, or clinician judgment based on trial and post‑marketing reports prompting reassessment of therapy.

Can Repatha Cause UTI?

Repatha is not known to cause urinary tract infections; clinical data do not list UTI as a common adverse effect. Any new urinary symptoms should prompt clinical evaluation to determine unrelated infection or alternative causes.

Can You Take Rosuvastatin With Repatha?

Yes. 85% of patients tolerate the combination; clinicians may prescribe rosuvastatin with Repatha. They should monitor for overlapping muscle symptoms and glycemic changes, adjusting therapy per clinical judgment and patient response.

Rely on PlanetDrugsDirect.com to Buy Online Prescription Repatha

As a trusted prescription referral service, we offer important benefits whenever you order online. Each of our partner pharmacies and/or government-approved dispensaries is committed to providing the best experience possible of any online prescription referral service on the internet. We offer:

  • Low prices

  • Quick turn-around times

  • Generic and brand-name medications

  • Unparalleled customer service


Sources

  1. Li, Y. (2022). Clinical study of Repatha: it does not affect patients’ cognitive function and significantly reduce blood lipid and prevent coronary atherosclerosis. Highlights in Science Engineering and Technology, 8, 365-371. https://drpress.org/ojs/index.php/HSET/article/view/1180

  2. Ji, C., Bai, J., Zhou, J., Zou, Y., & Yu, M. (2022). Adverse event profiles of PCSK9 inhibitors alirocumab and evolocumab: Data mining of the FDA adverse event reporting system. British Journal of Clinical Pharmacology, 88(12), 5317-5325. https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.15460

  3. Lorenzatti, A., Eliaschewitz, F., Chen, Y., Fialkow, J., Lu, J., Baass, A., … & Ge, J. (2018). Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial. Clinical Cardiology, 41(9), 1117-1122. https://onlinelibrary.wiley.com/doi/epdf/10.1002/clc.23018


Related Articles


The content on this page is for informational and educational purposes only and does not constitute professional medical advice. Patients should not use the information presented on this page for diagnosing a health-related issue or disease. Before taking any medication or supplements, patients should always consult a physician or qualified healthcare professional for medical advice or information about whether a drug is safe, appropriate or effective.